Used primarily in the development of antimalarial drugs, this compound serves as a key intermediate in synthesizing pharmaceutical agents that target the liver stages of Plasmodium parasites. Its structure supports activity against dormant parasite forms, making it valuable in treatments aimed at preventing relapse of malaria, especially in regimens targeting Plasmodium vivax and Plasmodium ovale. Additionally, it has shown potential in research for antimicrobial and antiparasitic applications due to its ability to intercalate into biological molecules and disrupt pathogen metabolism. Ongoing studies explore its role in novel drug formulations to improve efficacy and reduce toxicity in long-term therapies.